Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
9.03
+0.05 (0.56%)
At close: Aug 27, 2025, 4:00 PM
8.68
-0.35 (-3.88%)
After-hours: Aug 27, 2025, 5:27 PM EDT

Company Description

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum.

The company also offers delivery models that include full service, functional service provider, and hybrid service structures.

In addition, it delivers phase I – IV clinical trial management, clinical pharmacology, and consulting services.

Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines.

Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Fortrea Holdings Inc.
Fortrea Holdings logo
CountryUnited States
Founded1996
IndustryBiotechnology
SectorHealthcare
Employees16,120
CEOAnshul Thakral

Contact Details

Address:
8 Moore Drive
Durham, North Carolina 27709
United States
Phone877 495 0816
Websitefortrea.com

Stock Details

Ticker SymbolFTRE
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001965040
CUSIP Number34965K107
ISIN NumberUS34965K1079
Employer ID92-2796441
SIC Code8071

Key Executives

NamePosition
Anshul ThakralChief Executive Officer and Director
Jill McConnellChief Financial Officer
Mark A. MoraisChief Operating Officer and President of Clinical Services
Drayton VirklerPresident and Chief Commercial Officer
Robert ParksChief Accounting Officer
Alejandro Martinez GalindoChief Information Officer
Dave CooperChief Administrative Officer
Tracy H. KrummeSenior Vice President of Investor Relations
J. Stillman Hanson J.D.General Counsel and Corporate Secretary
Hima B. InguvaHead of Corporate Development

Latest SEC Filings

DateTypeTitle
Aug 27, 20258-KCurrent Report
Aug 19, 2025144Filing
Aug 19, 2025144Filing
Aug 14, 2025SCHEDULE 13GFiling
Aug 13, 2025SCHEDULE 13GFiling
Aug 6, 202510-QQuarterly Report
Aug 6, 2025SCHEDULE 13G/AFiling
Aug 6, 20258-KCurrent Report
Aug 5, 2025SCHEDULE 13G/AFiling
Jul 29, 2025SCHEDULE 13G/AFiling